+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients



Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients



Annals of Pharmacotherapy 36(12): 1929-1937



OBJECTIVE: To evaluate the use of proton-pump inhibitors (PPIs) for stress ulcer prophylaxis in critically ill adults. DATA SOURCES: Computerized biomedical literature search of MEDLINE (1966-June 2002) was conducted using the MeSH headings proton-pump inhibitor, ulcer, critical care, and acid. References of selected articles were reviewed. A manual search of critical care, surgery, trauma, gastrointestinal, and pharmacy journals was conducted to identify relevant abstracts. DATA SYNTHESIS: Traditional medications used for stress ulcer prophylaxis include antacids, histamine2 receptor antagonists (H2RAs), and sucralfate. Few studies have evaluated PPIs for stress ulcer prophylaxis. The majority of studies have demonstrated that enteral or intravenous administration of PPIs to critically ill patients elevates intragastric pH and consistently maintains pHgtoreq4.0. PPIs are safe and seem to be as efficacious as H2RAs or sucralfate for prevention of bleeding from stress-related mucosal damage (SRMD) and they may provide cost minimization. The small patient populations limit the results of comparative studies. CONCLUSIONS: Available data indicate that PPIs are safe and efficacious for elevating intragastric pH in critically ill patients. PPIs should be used only as an alternative to H2RAs or sucralfate since the superiority of PPIs over these agents for preventing SRMD-associated gastrointestinal bleeding has not been established. Additional comparative studies with adequate patient numbers and pharmacoeconomic analyses are needed before PPIs are considered the agents of choice for stress ulcer prophylaxis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011220954

Download citation: RISBibTeXText

PMID: 12452757

DOI: 10.1345/aph.1c151


Related references

Cost-Effectiveness of Highly Sensitive Cardiac Troponin T to Rule Out Acute Rejection After Heart Transplantation. Transplantation Proceedings 47(8): 2395-2396, 2015

Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits. World Journal of Gastrointestinal Endoscopy 3(3): 49-56, 2011

Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency. Thrombosis and Haemostasis 116(1): 58-68, 2016

Proton pump inhibitors therapy for esophageal eosinophilia: simply following consensus guidelines. Journal of Gastroenterology 46(5): 712, 2011

Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study. Journal of Infectious Diseases 213(3): 432-438, 2016

Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Québec, Canada. Canadian Journal of Public Health 101(3): 220-225, 2010

The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms. Reviews in Gastroenterological Disorders 3(Suppl. 4): S30-S39, 2003

Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiologica Scandinavica 59(5): 576-585, 2015

The Incidence Of Thrombocytopenia With Continuous Parenteral Pantoprazole Infusion. Chest 130(4): 206S-a-1-206S-a-2, 2006

Proton pump inhibitors and gastric acid secretion. American Journal of Gastroenterology 96(12): 3467-3468, 2001

Overuse of proton pump inhibitors and its consequences. Postepy Higieny i Medycyny Doswiadczalnej 70(0): 1112-1116, 2016

W1903 The Frequency and Outcome of Outpatient Management of Nonvariceal Upper Gi Hemorrhage: A Population-Based Analysis. Gastroenterology 134(4): A-730-A-731, 2008

W1018 Proton Pump Inhibitors for Prophylaxis of Nosocomial Upper Gastrointestinal Bleeding: the Impact of Standardized Guidelines On Prescribing Practice. Gastroenterology 136(5): A-636, 2009

The efficacy and safety of propiverine hydrochloride in patients with overactive bladder symptoms who poorly responded to previous anticholinergic agents. Advances in Urology 2011: 714978, 2011

Proton Modulation of Ranolazine Effects on Slow Inactivation in Sodium Channels. Biophysical Journal 104(2): 133a-134a, 2013